D
D. M. Sharp
Researcher at University of Hull
Publications - 31
Citations - 1389
D. M. Sharp is an academic researcher from University of Hull. The author has contributed to research in topics: Panic disorder & Agoraphobia. The author has an hindex of 20, co-authored 31 publications receiving 1324 citations. Previous affiliations of D. M. Sharp include University of Dundee & Castle Hill Hospital.
Papers
More filters
Journal ArticleDOI
A controlled comparison of eye movement desensitization and reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post-traumatic stress disorder
Kevin Power,Theresa McGoldrick,Keith M. Brown,Robin Buchanan,D. M. Sharp,Vivien Swanson,A. Karatzias +6 more
TL;DR: In this paper, a total of 105 patients with post-traumatic stress disorder (PTSD) were randomly allocated to eye-movement desensitization and reprocessing (EMDR) versus exposure plus cognitive restructuring (E + CR) versus waiting list (WL) in a primary care setting.
Journal ArticleDOI
Risk factors for the onset of non-specific neck pain: a systematic review
TL;DR: Female gender, older age, high job demands, low social/work support, being an ex-smoker, a history of low back disorders and a historyof neck disorders were linked to the development of non-specific neck pain.
Journal ArticleDOI
A controlled comparison of cognitive- behaviour therapy, Diazepam, and placebo, alone and in combination, for the treatment of generalised anxiety disorder
TL;DR: Outcome measures at end of treatment and at six months follow-up revealed the superiority of all Cognitive- Behaviour Therapy treatments, especially Cognitive-Behaviour Therapy alone, and Cognitive-behaviour Therapy + Diazepam.
Journal ArticleDOI
A comparison of the efficacy and acceptability of group versus individual cognitive behaviour therapy in the treatment of panic disorder and agoraphobia in primary care
TL;DR: In this article, the authors investigated the relative efficacy of a group treatment CBT and an individual CBT in comparison with a waiting list control group in the treatment of panic disorder with or without agoraphobia in primary care.
Journal ArticleDOI
Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia
D. M. Sharp,Kevin Power,Richard J. Simpson,Vivien Swanson,Eleanor Moodie,Julie A. Anstee,J.J. Ashford +6 more
TL;DR: The largest and most consistent treatment gains were evidenced by the Cognitive behaviour therapy and the Fluvoxamine + cognitive behaviour therapy groups, with the latter showing these gains 2 weeks earlier in treatment than those of the medication-alone groups.